semaglutide patent expiry in india Indian pharma companies launch low-cost generic Indian drugmakers gearing up to

Amy Schumer said Ozempic made her too weak to play with her young son, while Jameela Jamil says using it for the wrong reasons is creating a shortage for diabetics heres how others weighed in

The GLP-1 conversation is just beginning in Aotearoa and Im excited about the role we can play in supporting long-term health Business desk article: Our GLP-1 Support meals:

Our team is ready to discuss your specific needs and help you integrate high-quality and sustainable ingredients into your product line.

Rush obesity medicine specialist Christopher Chapman, MD, explains

Eli Lillys decision to hike the UK list price of its weight-loss drug Mounjaro by as much as 170% isnt just about affordability

Pharma and telehealth weight loss drug players should also provide transparent data on how many people experience which side effects when taking a GLP-1, while working with social media platforms to flag misleading content about medication efficacy and safety.